Virax Biolabs Group Limited Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Summary of Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Summary of Significant Accounting Policies - Summary of Consolidated Subsidiaries (Details)

v3.22.2

Summary of Significant Accounting Policies - Summary of Consolidated Subsidiaries (Details)	12 Months Ended
	Mar. 31, 2022
Virax Biolabs Group Limited
Disclosure of reclassifications or changes in presentation [line items]
Jurisdiction	Cayman Island
Incorporation Date	Sep. 02, 2021
Virax Biolabs (UK) Limited
Disclosure of reclassifications or changes in presentation [line items]
Jurisdiction	United Kingdom
Incorporation Date	Aug. 19, 2021
Ownership	100.00%
Virax Biolabs Limited (FKA- Shanghai Biotechnology Devices Ltd)
Disclosure of reclassifications or changes in presentation [line items]
Jurisdiction	Hong Kong
Incorporation Date	Apr. 14, 2020
Ownership	100.00%
Virax Immune T-Cell Medical Device Company Limited (FKA- Stork Nutrition Asia Limited)
Disclosure of reclassifications or changes in presentation [line items]
Jurisdiction	Hong Kong
Incorporation Date	Jan. 16, 2017
Ownership	100.00%
Virax Biolabs Pte. Limited
Disclosure of reclassifications or changes in presentation [line items]
Jurisdiction	Singapore
Incorporation Date	May 04, 2013
Ownership	95.65%
Logico Bioproducts Corp.
Disclosure of reclassifications or changes in presentation [line items]
Jurisdiction	BVI
Incorporation Date	Jan. 21, 2011
Ownership	95.65%
Shanghai Xitu Consulting Co., Ltd (FKA- Shanghai Logico Bioproducts)
Disclosure of reclassifications or changes in presentation [line items]
Jurisdiction	PRC
Incorporation Date	Oct. 27, 2017
Ownership	95.65%

- Definition

The country in which a subsidiary of the entity is incorporated. [Refer: Subsidiaries [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2021-01-01
-Paragraph 16
-Subparagraph b
-Clause ii
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b_ii&doctype=Standard
-URIDate 2021-03-24

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2021-01-01
-Paragraph 17
-Subparagraph b
-Clause ii
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b_ii&doctype=Standard
-URIDate 2021-03-24

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2021-01-01
-Paragraph 12
-Subparagraph b
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_b&doctype=Standard
-URIDate 2021-03-24

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2021-01-01
-Paragraph 19B
-Subparagraph b
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_19B_b&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The date of the end of the reporting period of the financial statements of a subsidiary.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2021-01-01
-Paragraph 11
-Subparagraph a
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_11_a&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_DateOfEndOfReportingPeriodOfFinancialStatementsOfSubsidiary
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfReclassificationsOrChangesInPresentationLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Subsidiaries [member]; Non-controlling interests]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2021-01-01
-Paragraph 12
-Subparagraph c
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_c&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
Namespace Prefix:	ifrs-full_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=vrax_ViraxBiolabsGroupLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=vrax_ViraxBiolabsUkLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=vrax_ViraxBiolabsLimitedFkaShanghaiBiotechnologyDevicesLtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=vrax_ViraxImmuneTCellMedicalDeviceCompanyLimitedFkaStorkNutritionAsiaLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=vrax_ViraxBiolabsPteLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=vrax_LogicoBioproductsCorpMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=vrax_ShanghaiXituConsultingCoLtdFkaShanghaiLogicoBioproductsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: